NCT01653015 Live Versus Inactivated Influenza Vaccine Study in Hutterite Children Status COMPLETED Phase PHASE4
NCT01651663 A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold Status UNKNOWN Phase PHASE4
NCT01649713 Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season Status COMPLETED Phase PHASE4
NCT01646138 Influenza A 2009 H1N1 Challenge Study in Healthy Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01640327 Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT01640314 Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT01631110 Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains Status COMPLETED Phase PHASE3
NCT01631071 Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains Status COMPLETED Phase NA
NCT01626820 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults Status COMPLETED Phase PHASE3
NCT01625689 Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine Status COMPLETED Phase PHASE2
NCT01623518 A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1 Status COMPLETED Phase PHASE1
NCT01617239 Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine Status COMPLETED Phase PHASE1
NCT01612000 Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01610245 Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza Status COMPLETED Phase PHASE3
NCT01609998 Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents Status COMPLETED Phase PHASE1
NCT01607112 A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT01599390 Influenza Burden Assessment in the United States, July1997 - up to April 2009 Status COMPLETED Phase N/A
NCT01592799 Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain Status COMPLETED Phase NA